Lam BL - Search Results

1

Training in Cortically Blinded Fields Appears to Confer Patient-Specific Benefit Against Retinal Thinning.

Fahrenthold BK, Cavanaugh MR, Tamhankar M, Lam BL, Feldon SE, Johnson BA, Huxlin KR. Fahrenthold BK, et al. Among authors: lam bl. Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):29. doi: 10.1167/iovs.65.4.29. Invest Ophthalmol Vis Sci. 2024. PMID: 38635245 Free PMC article.

2

Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.

OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group; Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, et al. Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961. Invest Ophthalmol Vis Sci. 2014. PMID: 25370513 Free PMC article. Clinical Trial.

3

Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Wall M, Johnson CA, Cello KE, Zamba KD, McDermott MP, Keltner JL; NORDIC Idiopathic Intracranial Hypertension Study Group. Wall M, et al. Invest Ophthalmol Vis Sci. 2016 Mar;57(3):805-12. doi: 10.1167/iovs.15-18626. Invest Ophthalmol Vis Sci. 2016. PMID: 26934136 Free PMC article. Clinical Trial.

4

The idiopathic intracranial hypertension treatment trial: design considerations and methods.

Friedman DI, McDermott MP, Kieburtz K, Kupersmith M, Stoutenburg A, Keltner JL, Feldon SE, Schron E, Corbett JJ, Wall M; NORDIC IIHTT Study Group. Friedman DI, et al. J Neuroophthalmol. 2014 Jun;34(2):107-17. doi: 10.1097/WNO.0000000000000114. J Neuroophthalmol. 2014. PMID: 24739993 Clinical Trial.

5

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. Wall M, et al. Among authors: lam bl. Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5. Neurology. 2015. PMID: 26245929 Free PMC article.

6

Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study.

Lam BL, Pennesi ME, Kay CN, Panda S, Gow JA, Zhao G, MacLaren RE; XIRIUS Study Group. Lam BL, et al. Ophthalmology. 2024 Sep;131(9):1083-1093. doi: 10.1016/j.ophtha.2024.02.023. Epub 2024 Feb 28. Ophthalmology. 2024. PMID: 38423215 Clinical Trial.

7

Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa.

Smith TB, Parker M, Steinkamp PN, Weleber RG, Smith N, Wilson DJ; VPA Clinical Trial Study Group; EZ Working Group. Smith TB, et al. PLoS One. 2016 Feb 4;11(2):e0148022. doi: 10.1371/journal.pone.0148022. eCollection 2016. PLoS One. 2016. PMID: 26845445 Free PMC article.

8

Prevalence of Molecular Diagnoses for Usher Syndrome and the Need for Coordinated Care.

Colbert BM, Smeal M, Cromar ZJ, Rosa P, Blanton SH, Lam BL, Liu XZ. Colbert BM, et al. Among authors: lam bl. Laryngoscope. 2024 Nov 19. doi: 10.1002/lary.31911. Online ahead of print. Laryngoscope. 2024. PMID: 39560289

9

Severe visual loss from concurrent fulminant idiopathic intracranial hypertension and malignant arterial hypertension: Prompt suspicion matters.

Aldhahwani B, Shah SM, Jiang H, Lam BL. Aldhahwani B, et al. Among authors: lam bl. Am J Ophthalmol Case Rep. 2024 Oct 18;36:102201. doi: 10.1016/j.ajoc.2024.102201. eCollection 2024 Dec. Am J Ophthalmol Case Rep. 2024. PMID: 39502455 Free PMC article.

10

XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa.

MacLaren RE, Duncan JL, Fischer MD, Lam BL, Meunier I, Pennesi ME, Sankila EK, Gow JA, Li J, Tsang SF; XOLARIS Study Group. MacLaren RE, et al. Among authors: lam bl. Ophthalmol Sci. 2024 Aug 13;5(1):100595. doi: 10.1016/j.xops.2024.100595. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39493534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters